Replies to post #145902 on Biotech Values

[pcrutch]

Unlikely to be commercially successful in combo with Nexavar. AE profile not great and efficacy not that much greater than Nexavar alone.

Spoke to a few KOLs who laughed at the idea of combining Nexavar and a drug like Tivantinib because the costs would be enormous.